Philippe Pourquier, Christopher Gioffre, Glenda Kohlhagen, yoshimasa Urasaki, François Goldwasser, et al.. Gemcitabine (2',2'-difluoro-2'-deoxycytidine), an antimetabolite that poisons topoisomerase I..
Clinical Cancer Research, American Association for Cancer Research, 2002, 8 (8), pp.2499-504.
⟨inserm-02438313⟩